SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)
Provided By GlobeNewswire
Last update: Aug 6, 2025
Trial now over 60% enrolled with 125 of 200 anticipated patients
Recent new site activation brings total clinical trial sites to 16
Read more at globenewswire.com
